Vietnam’s COVID-19 vaccine set to begin phase 3 trials in June
Vietnam’s domestically developed COVID-19 vaccine, Nano Covax, will begin Phase 3 of clinical trials in June involving up to 13,000 volunteers.
Phase 3 will be divided into smaller segments – with the first involving some 800-1,000 registered volunteers and will gradually expand to larger groups in future segments. If things go well, phase 3 trials could conclude by the end of September and commercial production could start soon after.
